Haven't used PLUVIA AS yet?
Ask Trustburn

Questions about PLUVIA AS

Based on 8 reviews, listing data and website checks · updated 2 days ago

What is PLUVIA AS?

PLUVIA AS is a spin-out from the University of Bergen in Norway that develops innovative therapies for patients with rare genetic disorders. The company focuses on creating small molecule pharmacological chaperones to stabilize and correct protein misfolding in loss-of-function diseases. Their lead development program targets phenylketonuria (PKU), a rare disorder caused by mutations in the enzyme phenylalanine hydroxylase that lead to toxic phenylalanine accumulation in the brain.

Which specific diseases is PLUVIA AS targeting with its current research?

The company's primary focus is developing a drug to improve the quality of life for children affected by the rare, congenital disease disorder known as phenylketonuria (PKU). They aim to leverage their unique drug discovery platform to target multiple rare diseases caused by protein misfolding beyond just PKU.

What is the main therapeutic candidate PLUVIA AS is currently developing?

According to the company's own website, their lead development program is specifically focusing on phenylketonuria (PKU). They intend to use their drug discovery platform to address multiple rare diseases that stem from protein misfolding issues.

What is the name of the drug candidate PLUVIA AS is developing for PKU?

The therapeutic candidate being developed is named PBAS499. This candidate is intended to stabilize and correct the misfolding of proteins involved in selected loss-of-function diseases, thereby rescuing the enzymatic activity needed to modify the disease.

Where is PLUVIA AS based and how is it connected to academia?

PLUVIA AS is located in Norway and operates as a spin-out from the University of Bergen. The company is based in Western Norway and is working to commercialize decade-long research on protein structure and protein misfolding.

Who are the recent investors supporting PLUVIA AS's drug development program?

The company recently announced that Mid Atlantic Bio Angels and Tidligfasekapital Vestland are investing in their drug development program. These new investors joined existing investors Sarsia and Investinor to support final preclinical development steps towards First-in-Human studies for PBAS499.

Who is the current CEO of PLuvia Biotech and what is their background?

Deborah Ramsdell was appointed as the new CEO of Pluvia Biotech in August 2026. She brings more than three decades of biotechnology leadership, regulatory, and clinical development experience with a strong focus on rare diseases.

What themes do multiple customer reviews on Trustburn share about PLUVIA AS?

Some reviewers on Trustburn praise the company for having exceptional customer service and top-notch products. Multiple reviewers mentioned that the team is always ready to help and answer any questions, describing the service as superb and the products as of the highest quality.

What is the current Trustburn rating and how many reviews does PLUVIA AS have?

The company has received a Trustburn rating of 4 out of 5 from 8 reviews. The reviews range from 3 to 5 stars, with the most recent reviews dating back to September 2023.

How does PLUVIA AS compare to other entities mentioned in recent news?

The company announced in May 2026 that the US PKU patient advocacy organization, the NPKUA, recently announced an investment from its membership base of experienced life science and pharmaceutical professionals to support Pluvia as it advances toward clinical development.

What are the next steps for PLUVIA AS according to their official announcements?

The company's website states that they are preparing to move PBAS499 into the clinic and look forward to working with the team, Board, investors, and the PKU community to bring a meaningful new treatment option to people living with PKU.

What is the historical research foundation behind PLUVIA AS's work?

The company's website states that they are working to commercialize decade-long research on protein structure and protein misfolding, which forms the basis of their therapeutic approach.

What is the official website of PLUVIA AS?

The official website of PLUVIA AS is pluviabiotech.com.

Based on reviews, listing data and the company's website. Verify anything important with the company directly.

Questions & Answers

No questions yet — be the first to ask.

News & Press

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying widget on your website — its a simple way to convert your visitors into customers.

Embed code

<script src="https://trustburn.com/widgets/index.js"></script>
<div class="trustburn-widget" data-trustburn-protocol="https:" data-trustburn-domain="trustburn.com" data-trustburn-widget="score" data-company-path="pluviabiotech-com" data-lang="en"></div>
More widgets

About PLUVIA AS

PLUVIA AS is developing a drug that will improve the quality of life of children affected by the rare, congenital disease disorder.